CHIZF vs LLY: Which Stock is Better?
Side-by-side comparison of China Traditional Chinese Medicine Holdings Co. Limited and Eli Lilly & Co in 2026
CHIZF
China Traditional Chinese Medicine Holdings Co. Limited
$0.27
LLY
Eli Lilly & Co
$919.90
Key Metrics Comparison
| Metric | CHIZF | LLY | Winner |
|---|---|---|---|
| Market Cap | $1.38B | $823.33B | LLY |
| P/E Ratio | N/A | 40.15 | LLY |
| EPS (TTM) | $N/A | $22.91 | LLY |
| Revenue Growth | -0.1% | 0.4% | LLY |
| Gross Margin | 48.1% | 83.0% | LLY |
Analyze CHIZF
Full quant analysis
Analyze LLY
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHIZF or LLY a better investment?
Comparing CHIZF and LLY: China Traditional Chinese Medicine Holdings Co. Limited has a market cap of $1.38B while Eli Lilly & Co has $823.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHIZF and LLY?
CHIZF (China Traditional Chinese Medicine Holdings Co. Limited) and LLY (Eli Lilly & Co) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHIZF or LLY?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHIZF or LLY?
LLY has higher revenue growth at 0.4% vs -0.1% for CHIZF.
Which company is more profitable: CHIZF or LLY?
Eli Lilly & Co (LLY) has higher gross margins at 83.0% compared to 48.1% for CHIZF.
Which is the larger company: CHIZF or LLY?
Eli Lilly & Co (LLY) is larger with a market cap of $823.33B compared to $1.38B for CHIZF.
Should I buy CHIZF or LLY in 2026?
Both CHIZF and LLY have investment merit. CHIZF trades at $0.27 while LLY trades at $919.90. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHIZF and LLY stock?
Key differences: Market Cap ($1.38B vs $823.33B), P/E Ratio (N/A vs 40.2x), Revenue Growth (-0.1% vs 0.4%), Gross Margin (48.1% vs 83.0%).